Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
28S ribosomal protein S35, mitochondrial (MRPS35) is a structural component of the mitochondrial small ribosomal subunit (28S), required for mitochondrial protein synthesis. The protein is encoded by a nuclear gene, translated in the cytoplasm, and then imported into mitochondria, where it assembles into the mitoribosome. It is essential for the translation of mitochondrial-encoded proteins, which are crucial for the function of the oxidative phosphorylation system. The MRPS35 gene is highly conserved and expresses in a wide range of tissues, with loss-of-function generally being lethal, highlighting its essential role in cellular energy metabolism. No drugs are known to specifically target MRPS35, and it is not considered a therapeutic target, but variants in MRPS35 or related proteins may result in mitochondrial disease phenotypes[1][3][8].
Not applicable (no known targeted drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 28S ribosomal protein S35, mitochondrial (MRPS35).